Calvert Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Calvert Investment Management's PFE Position: Q1 2017 in Review
Calvert Investment Management sold out of Pfizer (PFE) in Q1 2017, closing a stake of 788,990 shares — an estimated $24.3M sold.
Calvert Investment Management first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $34.1M in Q4 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.
- Calvert Investment Management reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
- Calvert Investment Management sold 788,990 Pfizer shares in Q1 2017, an estimated $24.3M.
- Calvert Investment Management first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
- Calvert Investment Management's Pfizer position peaked at $34.1M in Q4 2015.
- 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.
Based on Calvert Investment Management's 13F filing for Q1 2017.